These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

103 related articles for article (PubMed ID: 8768059)

  • 1. [APC (activated protein C) resistance and oral contraceptives].
    Kreis I; Weiss T; Rabe TN; Ziegler R; Nawroth PP
    Geburtshilfe Frauenheilkd; 1996 May; 56(5):231-3. PubMed ID: 8768059
    [TBL] [Abstract][Full Text] [Related]  

  • 2. [Risk of thrombosis with oral contraceptives: value of a thrombophilia screening test].
    Bauersachs R; Kuhl H; Lindhoff-Last E; Ehrly AM
    Vasa; 1996; 25(3):209-20. PubMed ID: 8967151
    [TBL] [Abstract][Full Text] [Related]  

  • 3. [Significance of hereditary thrombophilia for risk of thrombosis with oral contraceptives].
    Bauersachs R; Lindhoff-Last E; Ehrly AM; Kuhl H
    Zentralbl Gynakol; 1996; 118(5):262-70. PubMed ID: 8701622
    [TBL] [Abstract][Full Text] [Related]  

  • 4. [The routine coagulation tests along with activated protein C resistance (APC-R) in population of women applying for oral contraceptives].
    Kostecka I; Dabrowska M; Osada J; Suchowierska M; Wołczyński S
    Przegl Lek; 2001; 58(12):1038-40. PubMed ID: 12041017
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Effects of oral and transdermal hormonal contraception on vascular risk markers: a randomized controlled trial.
    Johnson JV; Lowell J; Badger GJ; Rosing J; Tchaikovski S; Cushman M
    Obstet Gynecol; 2008 Feb; 111(2 Pt 1):278-84. PubMed ID: 18238963
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Resistance to activated protein C in women using oral contraceptives.
    Spannagl M; Dick A; Assmann A; Heinemann L; Schramm W
    Semin Thromb Hemost; 1998; 24(5):423-30. PubMed ID: 9834008
    [TBL] [Abstract][Full Text] [Related]  

  • 7. A randomized cross-over study on the effects of levonorgestrel- and desogestrel-containing oral contraceptives on the anticoagulant pathways.
    Tans G; Curvers J; Middeldorp S; Thomassen MC; Meijers JC; Prins MH; Bouma BN; Büller HR; Rosing J
    Thromb Haemost; 2000 Jul; 84(1):15-21. PubMed ID: 10928463
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Thrombotic risk factors and oral contraception.
    Bokarewa MI; Falk G; Sten-Linder M; Egberg N; Blombäck M; Bremme K
    J Lab Clin Med; 1995 Sep; 126(3):294-8. PubMed ID: 7665978
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Effect of oral contraceptives on thrombin generation measured via calibrated automated thrombography.
    Tchaikovski SN; van Vliet HA; Thomassen MC; Bertina RM; Rosendaal FR; Sandset PM; Helmerhorst FM; Tans G; Rosing J
    Thromb Haemost; 2007 Dec; 98(6):1350-6. PubMed ID: 18064335
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Hemostatic effects of oral contraceptives in women who developed deep-vein thrombosis while using oral contraceptives.
    Bloemenkamp KW; Rosendaal FR; Helmerhorst FM; Koster T; Bertina RM; Vandenbroucke JP
    Thromb Haemost; 1998 Sep; 80(3):382-7. PubMed ID: 9759614
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Cardiovascular risk of oral contraceptives. Low, and mainly in women at risk.
    Prescrire Int; 1998 Aug; 7(36):118-24. PubMed ID: 10342951
    [TBL] [Abstract][Full Text] [Related]  

  • 12. [Contraceptive agents and risk of thrombosis].
    Maurer-Major E; Keller PJ
    Praxis (Bern 1994); 1997 Oct; 86(40):1543-8. PubMed ID: 9417570
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Oral contraception and thrombophilia.
    Blickstein D; Blickstein I
    Curr Opin Obstet Gynecol; 2007 Aug; 19(4):370-6. PubMed ID: 17625421
    [TBL] [Abstract][Full Text] [Related]  

  • 14. [19-year-old patient with thromboembolism caused by oral contraception].
    Pihusch R; de Coutre P; Salat C; Göhring P; Poley S; Hiller E
    Internist (Berl); 1996 Nov; 37(11):1163-6. PubMed ID: 9036113
    [No Abstract]   [Full Text] [Related]  

  • 15. The effect of different hormonal contraceptives on plasma levels of free protein S and free TFPI.
    Raps M; Helmerhorst FM; Fleischer K; Dahm AE; Rosendaal FR; Rosing J; Reitsma P; Sandset PM; van Vliet HA
    Thromb Haemost; 2013 Apr; 109(4):606-13. PubMed ID: 23407778
    [TBL] [Abstract][Full Text] [Related]  

  • 16. [The vascular risk of third generation contraceptive pills].
    Levesque H; Borg JY; Courtois H
    J Mal Vasc; 1997 Mar; 22(1):5-12. PubMed ID: 9120373
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Activated protein C resistance--a major risk factor for thrombosis.
    Rosén SB; Sturk A
    Eur J Clin Chem Clin Biochem; 1997 Jul; 35(7):501-16. PubMed ID: 9263726
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Sensitivity to activated protein C; influence of oral contraceptives and sex.
    Henkens CM; Bom VJ; Seinen AJ; van der Meer J
    Thromb Haemost; 1995 Mar; 73(3):402-4. PubMed ID: 7667823
    [TBL] [Abstract][Full Text] [Related]  

  • 19. [Contraceptive hormones, vascular risk and abnormal precipitation of serum gamma-globulins (author's transl)].
    Beaumont V; Lemort N; Lorenzelli L; Mosser A; Beaumont JL
    Pathol Biol (Paris); 1978 Dec; 26(9-10):531-7. PubMed ID: 85291
    [TBL] [Abstract][Full Text] [Related]  

  • 20. [Hormonal contraceptive agents as a risk factor in the development of acute thromboembolic diseases].
    Lambrekht R; Vageman V; Vinkelman B; Geĭnrikh P
    Khirurgiia (Mosk); 1986 Dec; (12):90-3. PubMed ID: 3821001
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 6.